Glenmark Pharma Receives FDA Approval For Anti-Inflammatory

Glenmark Pharmaceuticals has announced that it has received FDA approval for its generic version of Indomethacin tablets. The anti-inflammatory tablets are the generic equivalent of Indocin SR Extended-Release capsules, which are produced by Iroko Pharmaceuticals. According to IMS Health data, the tablets had annual sales of $6.3 million. Glenmark currently has 67 ANDAs which are pending FDA approval, and 118 drug products which are authorized for distribution in the US.

Read the source article at the Business Standard